AbCellera to Present at Upcoming Investor Conferences in March and April 2026
News > Health News
Audio By Carbonatix
4:05 PM on Wednesday, February 11
The Associated Press
VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb 11, 2026--
AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
- TD Cowen 46th Annual Health Care Conference, March 4, 2026
- KeyBanc Capital Markets Healthcare Forum, March 17, 2026
- Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026
A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260210650979/en/
CONTACT: Inquiries
Media: Tiffany Chiu;[email protected], +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.;[email protected], +1(604)559-9005
Investor Relations: Peter Ahn;[email protected], +1(778)729-9116
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY
SOURCE: AbCellera Biologics Inc.
Copyright Business Wire 2026.
PUB: 02/11/2026 04:05 PM/DISC: 02/11/2026 04:06 PM
http://www.businesswire.com/news/home/20260210650979/en